Cas:6990-27-8 N-[bromo(dimethylamino)boranyl]-N-methylmethanamine manufacturer & supplier

We serve Chemical Name:N-[bromo(dimethylamino)boranyl]-N-methylmethanamine CAS:6990-27-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-[bromo(dimethylamino)boranyl]-N-methylmethanamine

Chemical Name:N-[bromo(dimethylamino)boranyl]-N-methylmethanamine
CAS.NO:6990-27-8
Synonyms:Bromobis(dimethylamino)borane;MFCD00464744;Brom-bis-<dimethylamino>-boran;Bor-bis(dimethylamino)-bromid;Bis(dimethylamino)bromoboran;bis(dimethylamido)boron bromide;Boranediamine,1-bromo-N,N,N’,N’-tetramethyl;Bis-(dimethylamino)-borbromid;InChI=1/C4H12BBrN2/c1-7(2)5(6)8(3)4/h1-4H;1-Bromo-N,N,N inverted exclamation marka,N inverted exclamation marka-tetramethylboranediamine;Bis-(dimethylamino)-bromboran
Molecular Formula:C4H12BBrN2
Molecular Weight:178.86600
HS Code:2931900090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:20-28ºC0.5 mm Hg(lit.)
Density:1.259 g/mL at 25ºC(lit.)
Index of Refraction:n20/D 1.478(lit.)
PSA:6.48000
Exact Mass:178.02800
LogP:0.48940

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3398 4.3/PG 1
Packing Group:


Contact us for information like Bromobis(dimethylamino)borane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Bis-(dimethylamino)-bromboran physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Brom-bis-&lt Use and application,Bis(dimethylamino)bromoboran technical grade,usp/ep/jp grade.


Related News: Novartis and GSK carried out a swap of its vaccine and cancer drugs back in 2015. GSK paid $5.25 billion to Novartis for its vaccine business, and Novartis sent $16 billion for GSK’s oncology programs. Tafinlar and Mekinist had already been granted FDA approval at the time of that deal, and as a part of that deal, Novartis agreed to divest its own BRAF and MEK inhibitors to avoid creating a monopoly. 2-[bis(2-hydroxyethyl)amino]ethanol,butan-1-ol,(Z)-octadec-9-enoic acid,tetraethyl silicate manufacturers A thorough safety and risk analysis procedure should be administered at an appropriate time with documentation that adheres to the rules and regulations set forth by the regulatory authorities. (R)-(+)-2,2-dibromocyclopropanecarboxylic acid suppliers creating a Good Practice Exchange to develop, test and evaluate ways to ensure the right culture is created within the academic community, including to support and develop talent, tackle bullying and harassment and promote a system in which diversity of people and ideas can thrive N6-((2(tert-butyloxycarbonyl)amino)-carbonyl)-2′,3′,5′-tri-O-acetylguanosine vendor & factory.